International Oncology Alliance Launched in Foshan to Support Cross-Border Cancer Care

An international oncology collaboration network was launched at the first International Oncology Treatment Forum in Foshan, Guangdong, on 19 September 2026. Hosted by Fosun Health, the forum brought together specialists in oncology, radiotherapy and related fields. Yangcheng Evening News reported that more than 200 participants came from 15 countries and regions, including the United States, Indonesia, Bangladesh, Pakistan and Russia.

What the new alliance plans to do

Organizers announced the International Oncology Alliance during the forum. According to Fosun Health, it is intended to connect medical institutions and cancer specialists across borders for case discussion, professional exchange, referral coordination, teleconsultation and second opinions.

The proposed international consultation network is being developed. Its establishment should not be understood as a promise that every member hospital already offers remote appointments, accepts referrals or can treat every cancer type. Patients should confirm which institution and specialists would review their case, how their records will be shared, and whether a written opinion is available.

Why international patients are considering China

Forum discussions covered precision radiotherapy, cell therapy, biopharmaceuticals and the practical barriers to receiving care abroad. Shen Yun, a Fosun Health executive quoted by Yangcheng Evening News, said advances in Chinese diagnostic and treatment capabilities were drawing more overseas patients to Guangdong.

He cited one unspecified branded CAR-T product as an example of possible price differences: approximately CNY 1.2 million in China, US$375,000 in Singapore and as much as US$750,000 in the United States. These are figures attributed to the interviewee, not independently verified current quotes or comparable all-in treatment bills. The product, indication, hospital charges, insurance coverage, exchange rate and travel costs were not specified. Families should request a written estimate for their own case before making a decision.

A proposed pathway from first review to follow-up

Fosun Health says it is exploring a coordinated service model for international cancer patients:

1. Before travel: submit medical records through a designated overseas office or secure consultation channel for preliminary specialist review and, where available, a second opinion.
2. During care in China: arrange hospital assessment, language support and interpretation according to the hospital’s confirmed services.
3. After returning home: use scheduled remote follow-up and coordinate with a local treating clinician, subject to consent, local rules and clinician availability.

For patients, the most useful first step is a documented clinical review: confirmed diagnosis and pathology, recent imaging, prior treatment, current condition and specific questions for the specialist. Remote advice does not replace an in-person assessment, and treatment eligibility, visa decisions, insurance payment and outcomes cannot be assured by the alliance announcement.

Need help organizing a China care enquiry? Chinamedtravel can help prepare a confidential case summary and contact suitable licensed hospitals. Chinamedtravel was not identified in the source reports as an organizer or member of the International Oncology Alliance.

Editorial note: This article is an English adaptation and summary of Yangcheng Evening News reporting and Fosun Health’s announcement. Event participation and price statements are attributed to those sources. All three images are AI-generated editorial illustrations, not photographs of the event, its participants or actual patients. This article is news and general information, not medical or financial advice.